Immunoglobulins, normal human, for intravascular [Power / Sample Size]

posted by Yura – Belarus, 2016-01-13 07:51 (3818 d 06:36 ago) – Posting: # 15817
Views: 7,966

Hi
How to calculate the sample size for the non-comparative trials for biosimilar, or what are the approaches to solving this problem?
Aim - assessment of treatment effectiveness (improvement in symptoms).
Best regards,
Yura

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
341 visitors (0 registered, 341 guests [including 21 identified bots]).
Forum time: 15:27 CEST (Europe/Vienna)

Don’t compromise yourself.
You are all you’ve got.    Janis Joplin

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5